1-3 of 3
Maya Zlotnick, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Jonathan Canaani, MD, Ivetta Danilesko, MD, Noga Shem-Tov, MD, Maya Zlotnick, MD, Kira Lozinsky, Ohad Benjamini, Ronit Yerushalmi, MD, Meital Nagar, PhD, Chen Dor, PhD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-135947
Published: 2020
Journal Articles

Progression of Follicular Lymphoma within 24 Months of First Treatment (POD -24) As a Predictor of Overall Survival - a Single Center Retrospective Analysis

Guy Bitansky, Elena Vasilev, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Ohad Benjamini, MD, Arnon Nagler, MD MSc, Abraham Avigdor, MD, Meirav Kedmi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1534.
https://doi.org/10.1182/blood-2019-125218
Published: 2019
Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD
Journal: Blood
Blood (2016) 128 (22): 5429.
https://doi.org/10.1182/blood.V128.22.5429.5429
Published: 2016